Stock data

晶碩 (6491)

晶碩 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$750.98M, up 20.6% from a year earlier. EPS over the last four quarters totals NT$23.71.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 晶碩 in Insightr